"Caco-2 Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Human colonic ADENOCARCINOMA cells that are able to express differentiation features characteristic of mature intestinal cells, such as ENTEROCYTES. These cells are valuable in vitro tools for studies related to intestinal cell function and differentiation.
| Descriptor ID |
D018938
|
| MeSH Number(s) |
A11.251.210.190.160 A11.251.860.180.160 A11.436.140
|
| Concept/Terms |
Caco-2 Cells- Caco-2 Cells
- Caco 2 Cells
- Caco-2 Cell
- Cell, Caco-2
- Cells, Caco-2
|
Below are MeSH descriptors whose meaning is more general than "Caco-2 Cells".
Below are MeSH descriptors whose meaning is more specific than "Caco-2 Cells".
This graph shows the total number of publications written about "Caco-2 Cells" by people in this website by year, and whether "Caco-2 Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 3 | 3 |
| 1996 | 1 | 2 | 3 |
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 2 | 3 |
| 2002 | 3 | 0 | 3 |
| 2003 | 1 | 3 | 4 |
| 2004 | 2 | 8 | 10 |
| 2005 | 1 | 6 | 7 |
| 2006 | 0 | 5 | 5 |
| 2007 | 1 | 2 | 3 |
| 2008 | 0 | 7 | 7 |
| 2009 | 0 | 4 | 4 |
| 2010 | 0 | 5 | 5 |
| 2011 | 0 | 9 | 9 |
| 2012 | 0 | 12 | 12 |
| 2013 | 0 | 5 | 5 |
| 2014 | 0 | 6 | 6 |
| 2015 | 0 | 7 | 7 |
| 2016 | 0 | 4 | 4 |
| 2017 | 0 | 2 | 2 |
| 2018 | 0 | 4 | 4 |
| 2019 | 0 | 5 | 5 |
| 2020 | 0 | 4 | 4 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Caco-2 Cells" by people in Profiles.
-
Functional genome analysis and anti-Helicobacter pylori activity of a novel bacteriocinogenic Lactococcus sp. NH2-7C from Thai fermented pork (Nham). Sci Rep. 2023 11 21; 13(1):20362.
-
Distribution of P2Y and P2X purinergic receptor expression within the intestine. Am J Physiol Gastrointest Liver Physiol. 2024 02 01; 326(2):G107-G119.
-
Matrix metalloproteinase 7 contributes to intestinal barrier dysfunction by degrading tight junction protein Claudin-7. Front Immunol. 2022; 13:1020902.
-
The inhibition of intestinal glucose absorption by oat-derived avenanthramides. J Food Biochem. 2022 10; 46(10):e14324.
-
Angiotensin converting enzyme 2 is a novel target of the ?-secretase complex. Sci Rep. 2021 05 07; 11(1):9803.
-
Ribavirin shows antiviral activity against SARS-CoV-2 and downregulates the activity of TMPRSS2 and the expression of ACE2 in vitro. Can J Physiol Pharmacol. 2021 May; 99(5):449-460.
-
Association between histone deacetylase activity and vitamin D-dependent gene expressions in relation to sulforaphane in human colorectal cancer cells. J Sci Food Agric. 2021 Mar 30; 101(5):1833-1843.
-
Angiotensin-converting Enzyme 2-containing Small Extracellular Vesicles and Exomeres Bind the Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein. Gastroenterology. 2021 02; 160(3):958-961.e3.
-
Irinotecan-mediated diarrhea is mainly correlated with intestinal exposure to SN-38: Critical role of gut Ugt. Toxicol Appl Pharmacol. 2020 07 01; 398:115032.
-
A Chemical Switch for Transforming a Purine Agonist for Toll-like Receptor 7 to a Clinically Relevant Antagonist. J Med Chem. 2020 05 14; 63(9):4776-4789.